Blood Podcast

American Society of Hematology

Acute Myeloid Leukemia

Multiple Myeloma

Sickle Cell Disease

Venetoclax

CAR T-Cell Therapy

Diffuse Large B-Cell Lymphoma

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Clinical Trials

Transfusion Medicine

Follicular Lymphoma

Mantle Cell Lymphoma

Graft-Versus-Host Disease

Acute Lymphoblastic Leukemia

Myelodysplastic Syndromes

Tyrosine Kinase Inhibitors

Gene Therapy

Hematology

Venous Thromboembolism

Thrombosis

Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles. Subscribe and never miss a new episode.

117 ratings

Publishes	Weekly	Episodes	397	Founded	7 years ago
Number of Listeners		Categories	ScienceHealth & FitnessMedicine

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Mariateresa Fulciniti and Angelo D'Alessandro on their latest articles published in Blood. Dr. Fulciniti, of the Dana Farber Cancer Institute, discusses the development of "PKMYT1 i... more

Today • 30 min

MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Thomas Milne and Dominique Bonnet on their latest articles published in volume 147 issue 24 of Blood. Dr. Milne discusses how transcription factors simultaneously activate enhance... more

10 Sep 2026 • 24 min • Most popular

Predictive Markers of Glofitamab Resistance in R/R B-NHL

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Camille Laurent and Christine Bezombes on their latest article published in Blood titled "Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in re... more

3 Sep 2026 • 15 min • Popular

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

In this week's episode, Blood editor Laurie Sehn interviews Drs. Efstathios Kastritis and Lucia Chen on their latest articles published in Blood. Dr. Kastritis shares insights and results from the final survival analysis of the ANDROMEDA trial, which... more

27 Aug 2026 • 26 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The HematologistThe Hematologist

Two Onc DocsSam and Karine

HemeTalks: Conversations in Hematology EducationAmerican Society of Hematology

Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

Hematologic Oncology UpdateDr. Neil Love

Recent Guests

Thomas Milne

Co-author discussing the MYB/MIB paper on enhancer-gene crosstalk in ALL

MRC Molecular Hematology Unit, Institute of Molecular Medicine, University of Oxford, UK

Episode: MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

Dominique Bonnet

Co-author discussing the Venetoclax-Azacitidine impact on the bone marrow niche

Hematopoietic Stem Cell Laboratory, Francis Crick Institute, London

Episode: MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow

Camille Laurent

Researcher from Inserm Research Institute, Hospital of Toulouse

Inserm, Hospital of Toulouse

Episode: Predictive Markers of Glofitamab Resistance in R/R B-NHL

Christine Bezombes

Researcher from Inserm Research Institute, Hospital of Toulouse

Inserm, Hospital of Toulouse

Episode: Predictive Markers of Glofitamab Resistance in R/R B-NHL

Efstathios Kastritis

Lead author on Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in newly diagnosed amyloidosis (Andromeda)

University of Athens

Episode: Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

Lucia Chen

Lead author of Icaros Degradation by Mesigdomide Reduces T-cell Dysfunction and Improves the Efficacy of Anti-Myeloma T-cell Therapies

Oxford University

Episode: Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

Joshua Hill

From Fred Hutchinson Cancer Center, co-author of a review on preventing infections in adults receiving bispecific antibodies for lymphoma and myeloma

Fred Hutchinson Cancer Center

Episode: Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

Jeffrey Weitz

McMaster University researcher presenting on HRG interactions with platelets

McMaster University

Episode: Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

George Goshua

Expert presenting Haploidentical Transplant, Gene Therapy, and Standard of Care in Sickle Cell Disease cost-effectiveness analysis

Yale School of Medicine

Episode: Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal Hemoglobinopathies

Hosts

Laura Michaels

Host of Conversations with Blood Authors

James Griffin

Host of Conversations with Blood Authors / Blood Podcast

Reviews

4.2 out of 5 stars from 117 ratings

Great podcast that I learned to weekly
Podcast Addict
5
ZGDave
2 months ago
Zzzz
Listened to a 17-minute episode on Mantle Cell Lymphoma. The first 3 minutes were spent ego-stroking. The podcast content was relevant (though very surface level), but the presentation was so sleepy and boring.
Apple Podcasts
3
Pectown
United States6 months ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio. All the guests are great. Hosts are terrible sounding.
Apple Podcasts
2
adammgaines
United Statesa year ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio
Apple Podcasts
1
adammgaines
United Statesa year ago
That’s not how you do a podcast.
Have to agree with other reviewers. The computer generated reader is ghastly.
Apple Podcasts
1
Detritus2099
Australia3 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some listeners highlight the usefulness of CXCL9 and other biomarkers discussed.

Mixed feedback on audio quality and narration, with several listeners asking for more engaging delivery.

Positive notes about high-value scientific content and practical takeaways for clinicians.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#147	Italy/Science
Apple Podcasts	#87	India/Science
Apple Podcasts	#144	Hong Kong/Science
Apple Podcasts	#207	Mexico/Science
Apple Podcasts	#233	Saudi Arabia/Science
Apple Podcasts	#247	Singapore/Science

Talking Points

Recent interactions between the hosts and their guests.

Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

Q: How do you think the infection risk differences between bispecifics and traditional CD20 inhibitors arise—are we looking at solely a T-cell effect or additional factors?

It's broader than just T-cell involvement; factors include unique immune effects of bispecifics, patient treatment history, and the timing of administration, with ongoing immune dysregulation and chronic inflammatory states contributing to infection risk beyond B-cell and T-cell interactions.

Balancing Infection and Thrombosis: Bispecific Antibodies and the Many Roles of HRG

Q: Do you think there will be more standard guidelines for managing infection risk with bispecifics, or should practitioners rely on expert opinions like the ones discussed here?

There are multiple iterations of bispecifics and disease contexts, so guidelines will likely evolve; the present data from case series and reviews provide a framework that can be refined into guidelines as more standardized experience accumulates, particularly around target-specific infection risk and IVIG use.

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

Q: What is the potential role of maintenance therapy in this setting?

Maintenance with extended Daratumumab may deepen response or delay relapse, but the study did not definitively establish a maintenance benefit due to its design.

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

Q: What did the long-term update of Andromeda reveal about efficacy and safety?

Long-term data show sustained hematologic and organ responses with the Daratumumab-containing regimen and an overall survival benefit, without new safety signals, though there were more infections due to longer Daratumumab exposure.

Better Together: Adding daratumumab for AL Amyloidosis and and Mezigdomide for MM

Q: Perhaps you can start by providing some background on the clinical impact of AL amyloidosis and the current goals of therapy.

The condition presents with multi-organ involvement and high cardiovascular risk, so the goal has been to rapidly suppress the toxic light-chain production; using effective regimens early is critical to improve organ function and overall survival.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Blood Podcast

What is Blood Podcast about and what kind of topics does it cover?

A hematology-focused show featuring weekly discussions around the latest research, reviews, and clinical guidance across cancer, transplantation, immune therapies, and hematologic disorders. Episodes frequently pair a host with multiple expert guests to unpack recent papers, trial data, and review articles, often highlighting practical decision-making markers, prognostic tools, and novel therapies. Noteworthy traits include in-depth, academically rigorous conversations with leading clinicians and researchers, emphasis on translating findings to practice, and ongoing collaborations with major institutions and journals. This format is helpful for potential listeners seeking expert perspectives on cutting-edge hematology topics and for sponsor... more

Where can I find podcast stats for Blood Podcast?

Rephonic provides a wide range of podcast stats for Blood Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Blood Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Blood Podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Blood Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Blood Podcast?

Rephonic provides comprehensive predictive audience data for Blood Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Blood Podcast have?

To see how many followers or subscribers Blood Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Blood Podcast?

These podcasts share a similar audience with Blood Podcast:

1. The Hematologist
2. Two Onc Docs
3. HemeTalks: Conversations in Hematology Education
4. Blood Cancer Talks
5. Hematologic Oncology Update

How many episodes of Blood Podcast are there?

Blood Podcast launched 7 years ago and published 397 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Blood Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Blood Podcast?

Rephonic pulls ratings and reviews for Blood Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Blood Podcast?

Rephonic provides full transcripts for episodes of Blood Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Blood Podcast?

Recent guests on Blood Podcast include:

1. Thomas Milne
2. Dominique Bonnet
3. Camille Laurent
4. Christine Bezombes
5. Efstathios Kastritis
6. Lucia Chen
7. Joshua Hill
8. Jeffrey Weitz

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days